ChondroGene Inc.
North York, ON
Company Overview
ChondroGene is an applied genomics company focussed on developing novel diagnostics and therapeutics for human osteoarthritis (OA). The Company has 11 scientific staff and carries out research at its facilities in Toronto. ChondroGenes parent company, ChondroGene Limited, is a publicly held company listed on the TSX Venture Exchange under the stock symbol YDG.
Company Information
Physical Address
15-800 Petrolia Rd.
North York, ON M3J 3K4
CA
Mailing Address
15-800 Petrolia Rd.
North York, ON M3J 3K4
CA
Additional Details
Legal Name: ChondroGene Limited
Number of Employees: 13
CA
ChondroGene has constructed cDNA libraries from patient samples representing fetal, normal and various stages of OA disease progression. Characterization of the cDNA libraries has resulted in comprehensive identification of the genes that are expressed in human cartilage cells in health and disease. ChondroGene has also designed and constructed the first known human chondrocyte-specific microarray, the ChondroChip, an important platform technology for the identification and development of an early OA diagnostic and novel therapeutics.
6, 200 sq ft laboratory and office facility in Toronto
Contacts
Lenny Liscio
Title: Chief Financial Officer
Area of Responsibility: Finance/Accounting
Phone: Show phone
Fax: Show fax
Email: Show email
Services
- Genomic Research
Additional Information
541710